KMT2A and cancer: Among the top most significant EMT-specific hits, one-third belonged to the category of histone methylation writers, whereas several ERGs (including KMT2A, EP400, MBD5, and SRCAP) were found to be frequently targeted by genetic alterations in several cancer types (Fig. 2E).